摘要
微量残留白血病检测方法研究进展陈琳军丁训杰作者单位：上海医科大学附属华山医院血液学研究室（上海２０００４０）微量残留白血病（ｍｉｎｉｍａｌｒｅｓｉｄｕａｌｌｅｕｋｅｍｉａ，ＭＲＬ）是导致白血病复发，影响白血病患者长期存活的重要因素。兹将近年来重要检测...
出处
《肿瘤》
CAS
CSCD
北大核心
1998年第2期118-120,共3页
Tumor
同被引文献37
-
1王元鸿,荣会.毛细管气相色谱法分析人参中有机氯农药残留量[J].分析化学,1994,22(9):931-934. 被引量：40
-
2Lo wenberg G. Strategies in the treatment of acute myeloid leukemia. Haematologica, 2004, 89(9) :1029-1032.
-
3Suciu S, Mandelli F, Witte T, et al. Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1) : an intention-to- treat analysis of the EORTC/GIMEMAAML-10 trial. Blood, 2003,102(4) : 1232- 1240.
-
4Burnett AK, Goldstone AH, Stevens RM, et al. Randomised comparison of addition of autologous bone marrow transplantation to intensive chemotherapy for acute myeloid leukemia in first remission : results of MRC AML10 trial. UK Medical Research Council Adult and Children: s Leukemia Working Parties. Lancet, 1998, 351(9104): 700-708.
-
5Buccisano F, Maurillo L, Del Principe M,et al. Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia. Blood, 2012, 119(2) :332-341.
-
6Dinardo CD, Luger SM. Beyond morphology: minimal residual disease detection in acute myeloid leukemia: Curr Opin Hematol, 2012, 19(2) :82-88.
-
7Grimwade D, Vyas P, Freeman S . Assessment of minimal residual disease in acute myeloid leukemia. Curr Opin Oncol, 2010, 22(6):656-663.
-
8Lacombe F, Arnoulet C, Maynadi6 M,et al. Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic {actor: a GOELAMS study. Leukemia,2009,23(2):350-357.
-
9Shook D, Coustan-Smith E, Ribeiro RC, et al. Minimal residual disease quantitation in acute myeloid leukemia. Clin Lymphoma Myeloma,2OO9,9(Suppl 3) :$281-$285.
-
10Santamaria C, Chitl6n MC, Ferndndez C, et al. Using quantification of the PML-RAR alpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia. Haematologica, 2007, 92(3):315-322.
引证文献3
-
1陈果(综述),张曦(审校).微小残留白血病检测在急性髓系白血病治疗及预后判断中的意义及研究进展[J].国际输血及血液学杂志,2013,36(2):133-135. 被引量：3
-
2刘慧灵,张曙明,陈建民,张思巨.肉苁蓉中有机氯农药残留量测定[J].中药研究与信息,2000,2(4):20-22. 被引量：1
-
3文钦,陈果,钟江帆.微小残留白血病检测在AML治疗及预后判断中的意义[J].重庆医学,2015,44(29):4054-4056. 被引量：2
二级引证文献6
-
1吴玉玲,汪福康,汪琼,汪勇,余超,徐友善,王立鼎,吴晋安,章赛芜.动态监测微小残留病对急性白血病预后的临床意义[J].现代医药卫生,2016,32(2):185-187. 被引量：1
-
2李冰.动态监测微小残留病变在急性白血病治疗完全缓解后的临床意义[J].中国现代药物应用,2016,10(11):38-39. 被引量：2
-
3李丽君,刘蓓,徐茜,刘欢.急性髓系白血病患者化疗后微小残留病与多药耐药基因表达相关[J].基础医学与临床,2017,37(1):62-66. 被引量：8
-
4王博然,张海博,于奇宁,乌仁娜.AML患者诱导化疗疗效与预后关系分析[J].中国实验血液学杂志,2021,29(5):1417-1423. 被引量：5
-
5徐燕,张晶红,叶利锋.巩固治疗前微小残留病检测在老年急性髓系白血病预后中的临床意义[J].吉林医学,2023,44(9):2435-2438.
-
6蒋晔,刘红菊,郝晓花.中药中农药残留量研究进展[J].药学实践杂志,2004,22(2):68-72. 被引量：10
-
1郝梦哲,夏薇.微量残留白血病检测方法及对急性白血病的临床意义[J].中西医结合心血管病电子杂志,2016,4(29):31-31.
-
2白晓玲,赵洪宁,姚慧,郑楠,许波,孙念政,姜国胜,唐天华.WT1基因表达对儿童微量残留白血病检测的意义[J].中华血液学杂志,2002,23(7):372-373. 被引量：3
-
3杨胜,秘营昌.造血微环境和白血病[J].中国临床实用医学,2009,3(7):125-126.
-
4王春萍,费洪宝,汪俊华,刘树茂,杨爱德.应用聚合酶链反应技术检测微量残留白血病[J].中华儿科杂志,1996,34(1):19-21.
-
5毛平,张玉平,王彩霞,许艳丽,应逸,杜庆华,谢健晋,王顺清.AML-M5患者树突细胞诱导活化自体外周血T细胞增殖及克隆性分析[J].中华血液学杂志,2009,30(5):341-343.
-
6卢洁,谷仁凯,雷炜,佟琳如,董增义,周容.筑巢式聚合酶链反应动态检测儿童微量残留白血病的研究[J].中华儿科杂志,1997,35(9):464-466.
-
7曹萍,钟美佐,李晓林,刘英男,程英妮,齐振华,谢兆霞.淋巴细胞白血病基因诊断及微量残留白血病检测──PCR技术应用[J].中国现代医学杂志,1995,5(1):26-27.
-
8赵全,胡亚美.应用流式细胞术检测微量残留白血病[J].中华儿科杂志,1994,32(6):325-327. 被引量：1
-
9陈琳军,丁训杰,许小平,杨杰,阎影.以LacZ基因标记的大鼠微量残留白血病细胞的分布研究[J].中华血液学杂志,2000,21(2):63-66. 被引量：4
-
10叶启东,顾龙君,汤静燕,薛惠良,陈静,潘慈,董璐,周敏,蒋黎敏.MRD监测对儿童B系急性淋巴细胞性白血病疗效评估的意义[J].中国当代儿科杂志,2008,10(3):333-336. 被引量：7
